Aberrant expression of WDR5 is associated with several cancers, including bladder cancer, leukaemia, and prostate cancer and has been shown to facilitate cell growth, metastasis, and chemoresistance (Krivtsov and Armstrong 2007; Chen et al. 2015; Gu et al. 2017). The gene discussed is WDR5; the disease is Familial prostate cancer.